Trial
NCT06493578
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vyne Therapeutics Inc.
Collaborators
—
Condition
Non-segmental Vitiligo
Intervention
VYN201 Gel
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-21